[AVDL] YoY Quarter Result on 30-Sep-2018 [#Q3]

Stock
[AVDL] Avadel Pharmaceuticals plc
Announcement Date
05-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -358.73%
YoY- -172.75%
Quarter Report
AVDL's Result
AVDL's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Revenue 0 14,229 14,229 19,826 39,675 32,087 47,320 -
PBT -27,103 -16,743 -6,630 -16,462 27,600 -18,846 -20,766 4.53%
Tax -5,101 -5,040 2,234 -691 5,921 3,451 8,919 -
NP -22,002 -11,703 -8,864 -15,771 21,679 -22,297 -29,685 -4.86%
Tax Rate - - - - -21.45% - - -
Total Cost 22,002 25,932 23,093 35,597 17,996 54,384 77,005 -18.82%
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
NP Margin 0.00 -82.25 -62.30 -79.55 54.64 -69.49 -62.73 -
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
EPS -0.38 -0.20 -0.24 -0.43 0.54 -0.54 -0.73 -10.30%
EPS Diluted -0.38 -0.20 -0.24 -0.43 0.52 -0.54 -0.73 -10.30%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.